Issuers, get 33% more new shareholders with investorHub. Learn more
Looking for more information?
Contact our responsive and friendly client services team any time.
Recce Pharmaceuticals Ltd
Last trade: 10/06, 6:36AM
Talk to Recce Pharmaceuticals Ltd directly.
Sign up to their Investor Hub for direct access to the Recce Pharmaceuticals Ltd team, ask them questions, and see personal updates.
Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of antibiotics. RCE's portfolio of antibiotic therapies seek to address health threats posed by drug resistant bacteria. Their lead candidate RECCE®327 is designed as abroad-spectrum antibiotic, formulated using synthetic polymer technology to treat bacterial sepsis (blood poisoning) and other bacterial infections, including superbugs.
Level 36, Gateway, 1 Macquarie Pl, Sydney NSW 2000, Australia
Earnings per share
Dividend per share
(03) 9661 0441
Level 16, 452 Flinders St
Melbourne VIC 3000